Production (Stage)
Bright Minds Biosciences Inc.
DRUG
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.06M | 35.40K | -549.40K | 150.40K | -425.90K |
| Total Depreciation and Amortization | 15.70K | 15.40K | 13.90K | 13.20K | 13.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 446.80K | -1.03M | 127.40K | 124.00K | 171.30K |
| Change in Net Operating Assets | -96.60K | -84.70K | 68.50K | -112.10K | -356.00K |
| Cash from Operations | -1.69M | -1.07M | -339.60K | 175.50K | -597.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.60K | -23.80K | -23.90K | -22.00K | -22.00K |
| Issuance of Common Stock | 250.00K | 49.56M | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 2.51M | 300.00 | -- | -- |
| Cash from Financing | 157.00K | 37.18M | -17.30K | -16.00K | -16.30K |
| Foreign Exchange rate Adjustments | -11.70K | 1.16M | 12.20K | 28.90K | -1.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | 37.27M | -344.70K | 188.40K | -615.00K |